Study the impact of patents and compulsory licensing on the pricing of pharmaceutical products with anti-cancer and anti-retroviral drugs as on example

The Digital Institutional Repository of IIM Bangalore

Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/18470

DC Field	Value	Language
dc.contributor.advisor	Damodaran, Appukuttan	-
dc.contributor.author	Goel, Purnima
dc.contributor.author	Sivram, S D
dc.date.accessioned	2021-04-28T11:13:45Z	-
dc.date.available	2021-04-28T11:13:45Z	-
dc.date.issued	2011
dc.identifier.uri	https://repository.iimb.ac.in/handle/2074/18470	-
dc.description.abstract	This project aims to study the effect of patents and compulsory licensing on the pricing strategy of pharmaceutical firms. The role of regulation, both economic and political, like the Sherman Act of 1890 and the Competition Act of 2002 in India, on the pricing strategy would be considered. Another dimension of study would include as to how research for new drugs can be encouraged, without affecting social welfare.
dc.publisher	Indian Institute of Management Bangalore
dc.relation.ispartofseries	PGP_CCS_P11_324
dc.subject	Patents
dc.subject	Pharmaceutical industry
dc.subject	Pharmaceutical products
dc.subject	Drugs manufacturing
dc.subject	Pricing strategy
dc.title	Study the impact of patents and compulsory licensing on the pricing of pharmaceutical products with anti-cancer and anti-retroviral drugs as on example
dc.type	CCS Project Report-PGP
dc.pages	45p.
dc.identifier.accession	E38086
Appears in Collections:	2011

File	Size	Format
PGP_CCS_P11_324_E38086_ESS.pdf	1.12 MB	Adobe PDF	View/Open Request a copy

Check